Current Use of the Artificial Urinary Sphincter in Adult Females.


Journal

Current urology reports
ISSN: 1534-6285
Titre abrégé: Curr Urol Rep
Pays: United States
ID NLM: 100900943

Informations de publication

Date de publication:
24 Oct 2020
Historique:
accepted: 15 10 2020
entrez: 24 10 2020
pubmed: 25 10 2020
medline: 2 2 2021
Statut: epublish

Résumé

The aim of the present report was to review the recent evidences regarding the use of artificial urinary sphincter (AUS) in adult females. While the excellent functional outcomes of AUS in female patients with stress urinary incontinence (SUI) due to intrinsic sphincter deficiency (ISD) have been reported for decades, its use has remained confidential in most countries likely due to its challenging implantation and inherent morbidity. Over the past few years, laparoscopic and, more recently, robotic techniques of AUS implantation in female patients have been described with promising perioperative outcomes. As a result, the use of AUS has increased in several countries. The indications are mostly recurrent or persistent SUI after previous anti-incontinence procedures and neurogenic SUI. Owing to its unique potential to restore continence while maintaining low outlet resistance during the voiding phase, AUS may be of special interest in female patients with detrusor underactivity. High level of evidence data from trials which are underway, along with developments in robotic surgery and technological refinements of the device, may well, almost 50 years after its introduction, give to the AUS its momentum as a major contributor in the female SUI armamentarium. While the use of AUS in female patients has been restricted to some countries and a few high-volume centers, it has started spreading again over the past few years, thanks to the rise of minimally invasive approaches which facilitate its implantation, and this is yielding promising outcomes.

Identifiants

pubmed: 33098485
doi: 10.1007/s11934-020-01001-1
pii: 10.1007/s11934-020-01001-1
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

53

Commentaires et corrections

Type : CommentIn

Auteurs

Benoit Peyronnet (B)

Department of Urology, University of Rennes, Rennes, France. peyronnetbenoit@hotmail.fr.
Service d'Urologie, Hopital Pontchaillou, 2 rue Henri Le Guilloux, 35000, Rennes, France. peyronnetbenoit@hotmail.fr.

Tamsin Greenwell (T)

Department of Urology, University College London Hospital, London, UK.

Gary Gray (G)

Department of Urology, University of Alberta, Edmonton, Canada.

Rose Khavari (R)

Department of Urology, Houston Methodist Hospital, Houston, TX, USA.

Nikesh Thiruchelvam (N)

Department of Urology, Addenbrooke's Hospital, Cambridge, UK.

Grégoire Capon (G)

Department of Urology, University of Bordeaux, Bordeaux, France.

Jeremy Ockrim (J)

Department of Urology, University College London Hospital, London, UK.

Luis Lopez-Fando (L)

Department of Urology, University Hospital Ramon y Cajal, Madrid, Spain.

Jason Gilleran (J)

Department of Urology, William Beaumont Hospital, Royal Oak, MI, USA.

Georges Fournier (G)

Department of Urology, University of Brest, Brest, France.

Gommert A Van Koeveringe (GA)

Department of Urology, Maastricht University Medical Centre, Maastricht, Netherlands.

Frank Van Der Aa (F)

University Hospitals, KU Leuven, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH